Home › Sarcoma ng Malambot na Tisyu › District of Columbia
Pag-aaral pangklinika para sa Sarcoma ng Malambot na Tisyu sa District of Columbia
7 pag-aaral para sa Sarcoma ng Malambot na Tisyu ang naghahanap ng mga kalahok sa mga site sa District of Columbia.
Mga Lungsod sa District of Columbia
Opisyal na teksto ng pag-aaral (English)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma
- Sibley Memorial Hospital, Washington D.C.
Nagre-recruit
Hanggang edad 39 · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT06796543Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Children's National Medical Center, Washington D.C.
Nagre-recruitPhase 1/2
12 Months – 30 Years · Lahat ng kasarian · Na-update May 19, 2026 · NCT04901702Pre-operative Hypofractionated Proton Therapy
- Sibley Memorial Hospital, Washington D.C.
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 17, 2026 · NCT05917301Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- Children's National Hospital, Washington D.C.
Nagre-recruitPhase 1/2
Edad 2 hanggang 30 · Lahat ng kasarian · Na-update Peb 3, 2026 · NCT05734066Pediatric Radiation Therapy Registry
- Sibley Memorial Hospital, Washington D.C.
Nagre-recruitObservasyonal na pag-aaral
Edad 0 hanggang 26 · Lahat ng kasarian · Na-update Nob 5, 2025 · NCT07129317A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Children's National Medical Center, Washington D.C.
Nagre-recruitPhase 2
18 Months – 40 Years · Lahat ng kasarian · Na-update Ago 12, 2025 · NCT05135975Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.